C12N 2770/32261
Methods of inactivation or attenuation
C12N2770/32261 (Methods of inactivation or attenuation) appears on 5 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 4
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin9 Apr 2024US 11,952,603 B2Scientific Protein Laboratories, LLC
- Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin9 Oct 2018US 10,093,916 B2Scientific Protein Laboratories, LLC
- RNA interference functions as an antiviral immunity in mammals31 Jul 2018US 10,034,929 B2The Regents of the University of California
- Method of inhibiting picornavirus disease20 Jul 1993US 5,229,111 AWiscosnin Alumni Research Foundation
- Encephalomyocarditis virus vaccine25 May 1993US 5,213,795 AOxford
- Method for Reducing or Inactivating Viral and Microbial Content in the Processes for the Manufacture of Pancreatin20 Dec 2018US 2018/0362958 A1Scientific Protein Laboratories, LLC
- Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin9 Feb 2017US 2017/0037392 A1Scientific Protein Laboratories, LLC
- Rna interference functions as an antiviral immunity in mammals2 Feb 2017US 2017/0028051 A1The Regents of the University of California
- Pharmaceutical Compositions Comprising A Pancreatic Enzyme Preparation With Viral Infectivity Reduced Below A Significant Level And Methods Of Preparing And Using The Same16 Jan 2014US 2014/0017223 A1Aptalis Pharma Canada Inc.
Most cited
By later US patents